Approval · Notice of Compliance 11038 · 2010
LINESSA 21: Notice of Compliance 11038
Issued February 12, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11038
- Date
- February 12, 2010
- Company
- Schering-Plough Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to Contraindications, Warnings and Precautions, Adverse Reactions, Drug Interactions, Dosage and Administration, Overdosage, Clinical Pharmacology, Toxicology and References sections of the Product Monograph
- Therapeutic class
- Oral contraceptive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LINESSA 21 | Not yet assigned | — |
| LINESSA 28 | Not yet assigned | — |
Medicinal ingredients
- DESOGESTREL 0.1 MG per TAB
- ETHINYL ESTRADIOL 0.025 MG per TAB
- DESOGESTREL 0.125 MG per TAB
- DESOGESTREL 0.15 MG per TAB